Is Quest Diagnostics Incorporated overvalued?

Quest Diagnostics Incorporated (DGX) looks overvalued — trading about 41% above its fair value.

Overvalued

Price

$259.60

Fair value

$153.20

Current P/E

29.7

Normal P/E

17.5

Market cap

$28.56B

Dividend yield

1.3%

Return on equity

15.2%

Sector

Healthcare

Fair value compares DGX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks